Chimeric Antigens Receptor T Cell Therapy Improve the Prognosis of Pediatric Acute Lymphoblastic Leukemia With Persistent/Recurrent Minimal Residual Disease in First Complete Remission.

Published in:

Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.731435

By:

• Hu, Guan-hua;
• Cheng, Yi-fei;
• Zuo, Ying-xi;
• Chang, Ying-jun;
• Suo, Pan;
• Wu, Jun;
• Jia, Yue-ping;
• Lu, Ai-dong;
• Li, Ying-chun;
• Wang, Yu;
• Jiao, Shun-chang;
• Zhang, Long-ji;
• Zhao, Xiang-yu;
• Yan, Chen-hua;
• Xu, Lan-ping;
• Zhang, Xiao-hui;
• Liu, Kai-yan;
• Zhang, Le-ping;
• Huang, Xiao-jun

Publication type:

Article